학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 80건 | 목록 1~10
Academic Journal
Lukka PB; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland. Electronic address: pradeep.lukka@astrazeneca.com.; Tang W; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland.; Hammarstedt A; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Conrad T; Biometrics, Late-stage Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Heijer M; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Karlsson C; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Boulton DW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland.
Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Academic Journal
Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.; Lopez RB; Data Science, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Folkvaljon F; HTA Statistics & Data Science, Biopharmaceuticals BBU, AstraZeneca, Barcelona, Spain.; De Boer RA; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.; Cowie MR; Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Boston, MA.; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.; Kitzman DW; Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO.; Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.; Reicher B; AstraZeneca BioPharmaceuticals Research & Development, Late-stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, MD.; Senni M; University of Milano-Bicocca, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy.; Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.; Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.; McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-3297 (Electronic) Linking ISSN: 19413289 NLM ISO Abbreviation: Circ Heart Fail Subsets: MEDLINE
Academic Journal
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., K.F.D.).; Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., K.F.D.).; de Boer RA; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.).; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Kitzman DW; Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC (D.W.K.).; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; Maria Langkilde A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Reicher B; AstraZeneca BioPharmaceuticals Research & Development, Late-Stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, MD (B.R.).; Senni M; Cardiovascular Department, Papa Giovanni XXIII Hospital Bergamo, Italy (M.S.).; Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).; Wilderäng U; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Ontario, Canada (S.V.).; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Academic Journal
Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.; Neuen BL; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.; Jongs N; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Pollock C; Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.; Royal North Shore Hospital, St Leonards, NSW, Australia.; Greasley PJ; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Andersson EM; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Hammarstedt A; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Karlsson C; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Langkilde AM; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Wada T; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.; Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands. h.j.lambers.heerspink@umcg.nl.; The George Institute for Global Health, UNSW Sydney, Sydney, Australia. h.j.lambers.heerspink@umcg.nl.
Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Academic Journal
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.; McDowell K; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.; Welsh P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.; Osmanska J; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: https://twitter.com/Kieranfdocherty.; Anand I; Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minnesota, USA.; de Boer RA; Erasmus Medical Center, Department of Cardiology, Rotterdam, the Netherlands. Electronic address: https://twitter.com/UoGHeartFailure.; Køber L; Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Martinez FA; Instituto Docencia Asistencia Médica e Investigación Clinica, Cordoba National University, Cordoba, Argentina.; O'Meara E; Department of Cardiology, Montreal Heart Institute, Université de Montréal, Montréal, Quebec, Canada.; Ponikowski P; Wroclaw Medical University, Wroclaw, Poland.; Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Berg DD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; TIMI Study Group, Boston, Massachusetts, USA.; Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; TIMI Study Group, Boston, Massachusetts, USA.; Morrow DA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; TIMI Study Group, Boston, Massachusetts, USA.; Jarolim P; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Hammarstedt A; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Sjöstrand M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sattar N; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Academic Journal
Yeoh SE; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Campbell RT; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Hammarstedt A; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).; Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands (H.J.L.H.).; George Institute for Global Health, University of New South Wales, Sydney, Australia (H.J.L.H.).; Jarolim P; Department of Pathology (P.J.), Brigham and Women's Hospital, Boston, MA.; Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.).; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; Martinez FA; Universidad Nacional de Córdoba, Argentina (F.A.M.).; Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.).; Solomon SD; Division of Cardiovascular Medicine (S.D.S.), Brigham and Women's Hospital, Boston, MA.; Sjöstrand M; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).; Thrombolysis in Myocardial Infarction Study Group (M.S.S., D.A.M.), Brigham and Women's Hospital, Boston, MA.; Bengtsson O; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).; Greasley PJ; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (A.H., M.S., O.B., P.J.G.).; Sattar N; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Welsh P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).; Sabatine MSMorrow DA; Thrombolysis in Myocardial Infarction Study Group (M.S.S., D.A.M.), Brigham and Women's Hospital, Boston, MA.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., K.F.D., R.T.C., P.S.J., N.S., P.W., J.J.V.M.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Academic Journal
Adamson C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Welsh P; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, the Netherlands.; Diez M; Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina.; Drożdż J; Department Cardiology, Medical University of Lodz, Lodz, Poland.; Dukát A; Fifth Department of Internal Medicine, Comenius University, Bratislava, Slovakia.; Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut, USA.; Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri, USA; The George Institute for Global Health, University of New South Wales, Sydney, Australia.; Ljungman CEA; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.; Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland.; Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Morrow DA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Boulton DW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA.; Greasley PJ; Early Research and Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Sattar N; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.; Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Academic Journal
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).; Welsh P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).; Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Canada (S.V.).; De Boer RA; Department of Cardiology, University Medical Center and University of Groningen, The Netherlands (R.A.D.B.).; O'Meara E; Montreal Heart Institute, Université de Montréal, Canada (E.O.).; Bengtsson O; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Køber L; Rigshospitalet Copenhagen University Hospital, Denmark (L.K.).; Kosiborod MN; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.N.K.).; George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.).; Hammarstedt A; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Langkilde AM; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Lindholm D; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Little DJ; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Sjöstrand M; AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).; Martinez FA; George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.).; Ponikowski P; Wroclaw Medical University, Poland (P.P.).; Sabatine MS; TIMI (Thrombolysis in Myocardial Infarction) Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (M.S.S., D.A.M.).; Morrow DA; TIMI (Thrombolysis in Myocardial Infarction) Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (M.S.S., D.A.M.).; Schou M; Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark (M. Schou).; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (S.D.S.).; Sattar N; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Academic Journal
Sen T; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Scholtes R; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centres, Location VU University Medical Center, Amsterdam, The Netherlands.; Greasley PJ; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Cherney DZI; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Dekkers CCJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Vervloet M; Department of Nephrology and Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Danser AHJ; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.; Barbour SJ; Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Karlsson C; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Hammarstedt A; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Li Q; The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.; Laverman GD; Department of Internal Medicine, ZGT Hospital, Almelo and Hengelo, The Netherlands.; Bjornstad P; Department of Pediatrics, Division of Endocrinology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Medicine, Division of Nephrology, University of Colorado School of Medicine, Aurora, Colorado, USA.; van Raalte DH; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centres, Location VU University Medical Center, Amsterdam, The Netherlands.; Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Academic Journal
McDowell K; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Welsh P; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Morrow DA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, The Netherlands.; O'Meara E; Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.; Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA.; Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO, USA.; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.; Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.; Ponikowski P; Centre for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland.; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.; Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.; Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.; Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.; Solomon SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Sattar N; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Hammarstedt A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어